{"id":"https://openalex.org/W2803568902","doi":"https://doi.org/10.3892/or.2018.6465","title":"Montelukast, a cysteinyl leukotriene receptor antagonist, inhibits the growth of chronic myeloid leukemia cells through apoptosis","display_name":"Montelukast, a cysteinyl leukotriene receptor antagonist, inhibits the growth of chronic myeloid leukemia cells through apoptosis","publication_year":2018,"publication_date":"2018-05-25","ids":{"openalex":"https://openalex.org/W2803568902","doi":"https://doi.org/10.3892/or.2018.6465","mag":"2803568902","pmid":"https://pubmed.ncbi.nlm.nih.gov/29845257"},"language":"en","primary_location":{"id":"doi:10.3892/or.2018.6465","doi":"https://doi.org/10.3892/or.2018.6465","is_oa":true,"landing_page_url":"https://doi.org/10.3892/or.2018.6465","pdf_url":"http://www.spandidos-publications.com/10.3892/or.2018.6465/download","source":{"id":"https://openalex.org/S124357017","display_name":"Oncology Reports","issn_l":"1021-335X","issn":["1021-335X","1791-2431"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology Reports","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.spandidos-publications.com/10.3892/or.2018.6465/download","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032597296","display_name":"Ana Zovko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Ana Zovko","raw_affiliation_strings":["Department of Oncology-Pathology, Karolinska Biomics Center, Karolinska Institute, Solna, S-171 76 Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology-Pathology, Karolinska Biomics Center, Karolinska Institute, Solna, S-171 76 Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080558365","display_name":"Elham Yektaei\u2010Karin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Elham Yektaei-Karin","raw_affiliation_strings":["Department of Oncology-Pathology, Karolinska Biomics Center, Karolinska Institute, Solna, S-171 76 Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology-Pathology, Karolinska Biomics Center, Karolinska Institute, Solna, S-171 76 Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029450322","display_name":"D\u00e1niel Salamon","orcid":"https://orcid.org/0000-0001-6630-3993","observed_orcids":["https://orcid.org/0000-0001-6630-3993"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Daniel Salamon","raw_affiliation_strings":["Department of Women's and Children's Health, Karolinska Institute, Solna, S-171 76 Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Women's and Children's Health, Karolinska Institute, Solna, S-171 76 Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066611490","display_name":"Anders Nilsson","orcid":"https://orcid.org/0000-0002-0982-8483","observed_orcids":["https://orcid.org/0000-0002-0982-8483"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Anders Nilsson","raw_affiliation_strings":["Department of Oncology-Pathology, Karolinska Biomics Center, Karolinska Institute, Solna, S-171 76 Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology-Pathology, Karolinska Biomics Center, Karolinska Institute, Solna, S-171 76 Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054512616","display_name":"Jonas Wallvik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I90267481","display_name":"Ume\u00e5 University","ror":"https://ror.org/05kb8h459","country_code":"SE","type":"education","lineage":["https://openalex.org/I90267481"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Jonas Wallvik","raw_affiliation_strings":["Department of Public Health and Clinical Medicine, Ume\ufffd University, S-901 85 Ume\ufffd, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Public Health and Clinical Medicine, Ume\ufffd University, S-901 85 Ume\ufffd, Sweden","institution_ids":["https://openalex.org/I90267481"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002063554","display_name":"Leif Stenke","orcid":"https://orcid.org/0000-0002-3554-576X","observed_orcids":["https://orcid.org/0000-0002-3554-576X"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Leif Stenke","raw_affiliation_strings":["Department of Oncology-Pathology, Karolinska Biomics Center, Karolinska Institute, Solna, S-171 76 Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology-Pathology, Karolinska Biomics Center, Karolinska Institute, Solna, S-171 76 Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0952,"has_fulltext":true,"cited_by_count":22,"citation_normalized_percentile":{"value":0.77668962,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"40","issue":"2","first_page":"902","last_page":"908"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9603999853134155,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9603999853134155,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.010300000198185444,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/montelukast","display_name":"montelukast","score":1.0},{"id":"https://openalex.org/keywords/cysteinyl-leukotriene-receptor-1","display_name":"cysteinyl leukotriene receptor 1","score":0.9300000071525574},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9710000157356262},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8669999837875366},{"id":"https://openalex.org/keywords/leukotrienes","display_name":"leukotrienes","score":0.8759999871253967},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.777999997138977},{"id":"https://openalex.org/keywords/leukemia-stem-cells","display_name":"leukemia stem cells","score":0.8899999856948853},{"id":"https://openalex.org/keywords/wnt-beta-catenin-signaling","display_name":"Wnt/\u03b2-catenin signaling","score":0.8980000019073486},{"id":"https://openalex.org/keywords/bax","display_name":"Bax","score":0.7519999742507935},{"id":"https://openalex.org/keywords/caspase-3","display_name":"caspase-3","score":0.9330000281333923},{"id":"https://openalex.org/keywords/k562-cells","display_name":"K562 cells","score":0.8420000076293945},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitor-resistance","display_name":"tyrosine kinase inhibitor resistance","score":0.7670000195503235}],"concepts":[{"id":"https://openalex.org/C2776322731","wikidata":"https://www.wikidata.org/wiki/Q417767","display_name":"Montelukast","level":3,"score":0.8083548545837402},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6342658996582031},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.5430384278297424},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.45572346448898315},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4297310709953308},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4242997169494629},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.42054125666618347},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4168597161769867},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.4120723605155945},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36066317558288574},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32517415285110474},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.23705482482910156},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.13822564482688904},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068877","descriptor_name":"Imatinib Mesylate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000085","descriptor_name":"Acetates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003521","descriptor_name":"Cyclopropanes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013440","descriptor_name":"Sulfides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016044","descriptor_name":"Fusion Proteins, bcr-abl","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018077","descriptor_name":"Receptors, Leukotriene","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020014","descriptor_name":"K562 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020024","descriptor_name":"Leukotriene Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.3892/or.2018.6465","doi":"https://doi.org/10.3892/or.2018.6465","is_oa":true,"landing_page_url":"https://doi.org/10.3892/or.2018.6465","pdf_url":"http://www.spandidos-publications.com/10.3892/or.2018.6465/download","source":{"id":"https://openalex.org/S124357017","display_name":"Oncology Reports","issn_l":"1021-335X","issn":["1021-335X","1791-2431"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology Reports","raw_type":"journal-article"},{"id":"pmid:29845257","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29845257","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology reports","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.3892/or.2018.6465","doi":"https://doi.org/10.3892/or.2018.6465","is_oa":true,"landing_page_url":"https://doi.org/10.3892/or.2018.6465","pdf_url":"http://www.spandidos-publications.com/10.3892/or.2018.6465/download","source":{"id":"https://openalex.org/S124357017","display_name":"Oncology Reports","issn_l":"1021-335X","issn":["1021-335X","1791-2431"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322315","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691"},{"id":"https://openalex.org/F4320322971","display_name":"Ume\u00e5 Universitet","ror":"https://ror.org/05kb8h459"},{"id":"https://openalex.org/F4320324251","display_name":"Radiumhemmets Forskningsfonder","ror":"https://ror.org/006hbj696"},{"id":"https://openalex.org/F4320335013","display_name":"Socialstyrelsen","ror":"https://ror.org/01v4pc162"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2803568902.pdf","grobid_xml":"https://content.openalex.org/works/W2803568902.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W1981711965","https://openalex.org/W1989931702","https://openalex.org/W2003789147","https://openalex.org/W2007187686","https://openalex.org/W2008945391","https://openalex.org/W2013225336","https://openalex.org/W2018195863","https://openalex.org/W2019561936","https://openalex.org/W2024224319","https://openalex.org/W2027849826","https://openalex.org/W2040645445","https://openalex.org/W2042134520","https://openalex.org/W2053310263","https://openalex.org/W2057918772","https://openalex.org/W2080469841","https://openalex.org/W2107505341","https://openalex.org/W2112662898","https://openalex.org/W2133514206","https://openalex.org/W2152792159","https://openalex.org/W2160811827","https://openalex.org/W2404379596","https://openalex.org/W2522909715","https://openalex.org/W2560744432","https://openalex.org/W2622222492"],"related_works":["https://openalex.org/W2534566414","https://openalex.org/W2560744432","https://openalex.org/W2549984034","https://openalex.org/W2567529851","https://openalex.org/W2625393991","https://openalex.org/W4238703952","https://openalex.org/W3084350744","https://openalex.org/W2519666751","https://openalex.org/W4415381769","https://openalex.org/W2523741630"],"abstract_inverted_index":{"The":[0],"clinical":[1],"outcome":[2],"for":[3,100,146,254],"patients":[4],"with":[5,13,94,120,168],"chronic":[6],"myeloid":[7],"leukemia":[8],"(CML)":[9],"has":[10,77,103],"improved":[11],"significantly":[12],"the":[14,47,95,106,125,142,147,153,163,265],"introduction":[15],"of":[16,31,42,46,86,91,108,127,144,149,162,165,188,203,252,267],"tyrosine":[17],"kinase":[18],"inhibitors":[19],"(TKIs).":[20],"However,":[21],"their":[22,171],"curative":[23],"potential":[24],"appears":[25],"limited,":[26],"probably":[27],"as":[28,39],"a":[29,40,67,84,225,250],"consequence":[30],"TKI-resistant":[32],"leukemic":[33],"stem":[34],"cells":[35,134,151,167,206,269],"(LSCs)":[36],"that":[37,61,114,242],"persist":[38],"result":[41],"aberrant":[43],"pathways":[44,272],"independent":[45],"well-established":[48],"oncoprotein":[49],"Bcr-Abl.":[50],"One":[51],"such":[52],"pathway":[53],"involves":[54],"signaling":[55,234],"through":[56,270],"leukotrienes":[57],"(LTs),":[58],"bioactive":[59],"compounds":[60],"have":[62],"been":[63,78],"suggested":[64],"to":[65,80,231],"play":[66],"role":[68],"in":[69,83,105,118,224,247,261,281],"several":[70],"other":[71],"malignancies.":[72],"Cysteinyl":[73],"LT1":[74],"receptor":[75,93],"(CysLT1R)":[76],"reported":[79],"be":[81],"overexpressed":[82],"number":[85],"solid":[87],"cancers,":[88],"and":[89,152,217,239,273],"blocking":[90],"this":[92,248],"antagonist":[96],"montelukast":[97,157,228,243],"(treatment":[98],"approved":[99],"bronchial":[101],"asthma)":[102],"resulted":[104],"killing":[107,202,266],"cancer":[109],"cells.":[110,190],"We":[111],"recently":[112],"demonstrated":[113],"montelukast,":[115,258],"alone":[116],"or":[117],"combination":[119],"imatinib,":[121],"can":[122],"effectively":[123],"reduce":[124],"growth":[126,172],"CML":[128,150,205,268],"cells,":[129,181],"while":[130,182],"normal":[131],"bone":[132],"marrow":[133],"were":[135],"left":[136],"unaffected.":[137],"Herein,":[138],"we":[139,240],"further":[140,222],"investigated":[141],"importance":[143],"CysLT1R":[145,164,199,238],"survival":[148],"mechanisms":[154],"by":[155,173,194,198,209,237],"which":[156],"induces":[158,264],"cell":[159],"death.":[160],"Knockdown":[161],"K562":[166],"siRNA":[169],"reduced":[170],"25%.":[174],"Montelukast":[175],"had":[176],"no":[177],"effect":[178],"on":[179],"these":[180],"it":[183],"killed":[184],"more":[185],"than":[186],"50%":[187],"CysLT1R-expressing":[189],"Growth":[191],"inhibition":[192],"exerted":[193],"imatinib":[195],"was":[196,207,229,235],"unaffected":[197],"status.":[200],"Montelukast-induced":[201],"K562/JURL-MK1":[204],"paralleled":[208],"Bax":[210],"overexpression,":[211],"cytochrome":[212],"c":[213],"release,":[214],"PARP-1":[215],"cleavage,":[216],"caspase-3":[218],"activation,":[219],"an":[220,276],"event":[221],"increased":[223],"setting":[226],"where":[227],"added":[230],"imatinib.":[232],"Wnt/\u03b2-catenin":[233],"activated":[236],"observed":[241],"could":[244],"induce":[245],"proteins":[246],"pathway,":[249],"finding":[251],"relevance":[253],"LSC":[255],"survival.":[256],"Thus,":[257],"employed":[259],"at":[260],"vivo-like":[262],"concentrations,":[263],"apoptotic":[271],"may":[274],"provide":[275],"additional,":[277],"novel":[278],"therapeutic":[279],"possibility":[280],"CML.":[282]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2018-06-01T00:00:00"}